Navigation Links
Etirinotecan Pegol (NKTR-102) Passes Interim Efficacy Analysis for BEACON Pivotal Phase 3 Clinical Study in Patients with Metastatic Breast Cancer
Date:1/14/2014

rates (ORR), clinical benefit rate, duration of response, pharmacokinetics, safety, quality-of-life measurements, and pharmacoeconomic implications.  The study is also evaluating specific biomarker data to assess correlation with objective tumor response rates, progression-free survival, overall survival and selected toxicities.About Etirinotecan Pegol (NKTR-102)NKTR-102 is a new therapeutic option in development for advanced breast cancer.  It is the first long-acting topoisomerase I inhibitor with a non-overlapping mechanism of action with other agents used to treat breast cancer, which may mitigate potential cancer cross-resistance and reduce overlapping toxicities.  In November 2012, NKTR-102 was designated a Fast Track development program by the U.S. FDA for the treatment of patients with locally recurrent or metastatic breast cancer progressing after treatment with ATC.

NKTR-102 is believed to penetrate the vasculature of the tumor environment more readily than normal vasculature, increasing the concentration of active drug within tumor tissue to enhance anti-tumor activity. The unique PK profile of NKTR-102 provides continuous exposure of active drug throughout the entire chemotherapy cycle, with reduced peak exposures that can be associated with toxicities. In addition to metastatic breast cancer, NKTR-102 is also being evaluated for the treatment of ovarian, colorectal, glioma and lung cancers.

About Metastatic Breast CancerMore than one million women worldwide are diagnosed with breast cancer globally every year. (2) The chance of developing invasive breast cancer at some time in a woman's life is a little less than one in eight (12%). There are approximately 200,000 new cases of breast cancer in the United States and 430,000 in Europe each year. (3) Metastatic breast cancer refers to cancer that has spread from the breast to distant sites in the body.

Anthracyclines
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
2. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
3. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
4. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
5. CAS REGISTRY(SM) surpasses 75 million small molecules
6. WuXi Manufacturing Facility Passes FDA Inspection
7. Tecfideras Patient Share at Three Months Postlaunch Surpasses That for Aubagio and Gilenya At the Same Stage of Their Launches
8. Emotivs Brainwear Technology To Track Cognitive Health Surpasses $1M Kickstarter Stretch Goal
9. The Leukemia & Lymphoma Society Co-Pay Assistance Fund Surpasses $200 Million
10. French Man with SynCardia Total Artificial Heart Surpasses Two Years of Support
11. NABPs .PHARMACY Proposal Passes Initial ICANN Evaluation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... N.J. , Dec. 17, 2014  IGI Laboratories, ... today the closing of its offering of $125 million ... 2019 (the "Notes").  The Notes were offered and sold ... under the Securities Act of 1933, as amended (the ... a fixed rate of 3.75% per year, payable semiannually ...
(Date:12/15/2014)... , December 15, 2014 ... Am 19. und 20. Februar sind ... Aegate SAFE MEDICINE ECOSYSTEM PARTNER PROGRAMM ™ ... zu besuchen. Diese Tagung soll ... die Möglichkeit geben, die neue profitablen Unternehmensdienstleistungen, ...
(Date:12/15/2014)... 12, 2014 Research and Markets ... http://www.researchandmarkets.com/research/ms3j8c/cardiac ) has announced the addition of the ...  report to their offering. Global Guidewires sector is ... North America accounts for nearly 35% ... claims approximately 25% (2018). Asia-Pacific ...
Breaking Medicine Technology:IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam 2Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 2Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 3Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 4
... , CLEVELAND , Feb. 9 DATATRAK International, ... eClinical solutions for the clinical trials industry, today announced that it ... seminar in Tel Aviv, Israel , focusing on eClinical solutions ... will identify and decipher the challenges, costs and obstacles customarily encountered ...
... , Feb. 9 Visage Imaging®, Inc., a wholly ... John Danahy joins as General Manager North America , ... industry, Johns brings a wealth of experience to the Visage team. ... managed the national sales organization and developed new business opportunities in ...
Cached Medicine Technology:DATATRAK International and PFC Pharma Focus to Co-Sponsor eClinical Solutions Seminar in Tel Aviv 2DATATRAK International and PFC Pharma Focus to Co-Sponsor eClinical Solutions Seminar in Tel Aviv 3DATATRAK International and PFC Pharma Focus to Co-Sponsor eClinical Solutions Seminar in Tel Aviv 4Visage Imaging Names John Danahy as General Manager North America, Sales and Services 2
(Date:12/19/2014)... December 19, 2014 B. E. Smith, ... healthcare providers, has been retained to lead a national ... Medical Center in Estes Park, Colo. The top executive ... has recently placed more than 900 healthcare executives into ... a 25-bed, not-for-profit critical access hospital and level IV ...
(Date:12/19/2014)... Hands On Mobile Spa, has announced they now have a ... been transformed into a utopia for the Long Island community ... The Virtual Tour showcases the beauty of the Spa On ... more. , The Virtual Tour shows viewers each of the ... overhauled Winnebago. Marla Kaplan-Pelle, Director states " It's hard to ...
(Date:12/19/2014)... Slone Partners , a national recruitment ... technology, and laboratory testing industries, has promoted Leslie ... The announcement comes after a year of expansion ... in Boston and several new additions to the ... client experience," said Adam Slone, Chief Executive Officer. ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 The ... ski club in Southern Vermont’s Deerfield Valley, announced today ... inspired by classic rock songs. , Three time ... with a private concert followed by a trail naming ... new trail names include: “I’m Alright” the theme song ...
(Date:12/19/2014)... HealthDay Reporter THURSDAY, Dec. ... were exposed to high levels of air pollution late in ... U.S. study suggests. Researchers found that of nearly 1,800 ... exposed to the most air pollution during pregnancy were twice ... And exposure during the third trimester, specifically, showed the strongest ...
Breaking Medicine News(10 mins):Health News:Estes Park Medical Center Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Estes Park Medical Center Retains B. E. Smith to Recruit New Chief Financial Officer 3Health News:A Virtual Tour Of Hands On Mobile Massage Spa Is Now Available 2Health News:A Virtual Tour Of Hands On Mobile Massage Spa Is Now Available 3Health News:Slone Partners Promotes Leslie Loveless to Chief Operating Officer 2Health News:The Hermitage Club Officially Names Four Ski Trails after Iconic Rock Songs by Grammy Award Winner Kenny Loggins 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 3
... Lingering physical effects of cancer a likely cause, finds study, ... fighting cancer wasn,t hard enough, a new Dutch study concludes ... be able to find a job. , The meta-analysis of ... those who,d battled cancer were out of work vs. 15.2 ...
... Hospital of Paris Joins The Global Prevention Network(TM) ... U.S. Preventive Medicine(R), the leader in disease prevention ... American Hospital of Paris to jointly deliver preventive ... serve as a referral Center of Excellence for ...
... of trying to figure out the ,Nanny Tax,CHICAGO, Feb. 17 ... are two things parents never imagined they,d see in ... exciting female political figures having issues due to this type ... That,s why Sittercity.com, America,s largest and most trusted online source ...
... was approved as a routine vaccination for girls aged 11 ... series of shots that protect against human papillomavirus, which is ... a majority of teen girls, parents and young women in ... to a new policy brief released today by the UCLA ...
... Ore. New research at Oregon Health & Science University,s ... HIV in the initial stages of infection before ... a successful approach in limiting the spread of the disease. ... the journal Nature Medicine and will appear in ...
... of the American Recovery and Investment Act of 2009 ... Republican Senator Arlen Specter of Pennsylvania for his leadership ... Institutes of Health (NIH). , "Senator Specter has ... research and to the fight against cancer," said Margaret ...
Cached Medicine News:Health News:One in Three Cancer Survivors on Unemployment Line 2Health News:One in Three Cancer Survivors on Unemployment Line 3Health News:U.S. Preventive Medicine(R), American Hospital of Paris Sign Affiliation Agreement to Deliver Preventive Medicine Services 2Health News:U.S. Preventive Medicine(R), American Hospital of Paris Sign Affiliation Agreement to Deliver Preventive Medicine Services 3Health News:Sittercity.com Makes Nanny Taxes Less Taxing 2Health News:Sittercity.com Makes Nanny Taxes Less Taxing 3Health News:1 in 4 California adolescent girls has had HPV vaccine 2Health News:OHSU vaccine research targets HIV in the slower, early stage of infection 2Health News:American Association for Cancer Research lauds Senator Arlen Specter 2
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
... line of flowmeters, available in oxygen, ... They are all available in a ... your application. With color coded labels ... in use, the Amvex Flowmeter is ...
... a complete line of flowmeters, available ... 2 . They are all available ... best suit your application. With color ... the gas in use, the Amvex ...
... complete line of flowmeters, available in oxygen, air, heliox ... a variety of calibrations to best suit your application. ... gas in use, the Amvex Flowmeter is a user ... with I. For Power Take-Off add PT to the ...
Medicine Products: